Different recovery profiles of coagulation factors, thrombin generation, and coagulation function after hemorrhagic shock in pigs

Journal of Trauma and Acute Care Surgery

Volumn 73, Issue 3, 2012, Pages 640-647

  Martini, Wenjun Z ^a   Cortez, Douglas S ^a   Dubick, Michael A ^a   Blackbourne, Lorne H ^a  

^a US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

fibrinogen; Hemorrhagic shock; platelets; thromboelastography

Indexed keywords

BLOOD CLOTTING FACTOR; FIBRINOGEN; RINGER LACTATE SOLUTION;

ANIMAL EXPERIMENT; ARTICLE; BLOOD CLOTTING; BLOOD VOLUME; CONTROLLED STUDY; HEART RATE; HEMODYNAMICS; HEMORRHAGIC SHOCK; MEAN ARTERIAL PRESSURE; NONHUMAN; PRIORITY JOURNAL; RANDOMIZATION; RESUSCITATION; SHAM PROCEDURE; THROMBIN TIME; THROMBOCYTE COUNT;

ANIMALS; BLOOD COAGULATION; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FIBRINOGEN; HEMODYNAMICS; MALE; PLATELET COUNT; RANDOM ALLOCATION; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SHOCK, HEMORRHAGIC; SURVIVAL RATE; SUS SCROFA; SWINE; THROMBELASTOGRAPHY; THROMBIN TIME; TIME FACTORS;

EID: 84865965549     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e318253b693     Document Type: Article

References (25)

1. Bellamy RF. The causes of death in conventional land warfare: implications for combat casualty care research. Mil Med. 1984;149:55-62.
2. Sherman LA. DIC in massive transfusion. Prog Clin Biol Res. 1982;108: 171-189.
3. Stahel PF, Moore EE, Schreier SL, Fierl MA, Kashuk JL. Transfusion strategies in postinjury coagulopathy. Curr opin Anaesthesiol. 2009;22:289-298.
4. Cotton BA, Gunter OL, Isbell J, et al. Damage control hematology: the impact of a trauma exsanguination protocol on survival and blood product utilization. J Trauma. 2008;64:1177-1182; discussion 1182-1173.
5. Hardy JF, De Moerloose P, Samama M: Groupe d'intérêt en Hémostase Périopératoire. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth. 2004;51: 293-310.
6. Mann KG, Brummel K, Butenas S. What is all that thrombin for? J Thromb Haemost. 2003;1:1504-1514.
7. Hoffman M, Monroe DM III. A cell-based model of hemostasis. Thromb Haemost. 2001;85:958-965.
8. Schreiber MA. Coagulopathy in the trauma patient. Curr Opin Crit Care 2005;11:590-597.
9. Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma. 2009;67:266-275, discussion 275-266.
10. Martini WZ, Chinkes DL, Sondeen J, Dubick MA. Effects of hemorrhage and lactated Ringer's resuscitation on coagulation and f ibrinogen metabolism in swine. Shock. 2006;26:396-401.
11. Martini WZ, Cortez DS, Dubick MA, Park MS, Holcomb JB. Thrombelastography is better than PT, aPTT, and activated clotting time in detecting clinically relevant clotting abnormalities after hypothermia, hemorrhagic shock and resuscitation in pigs. J Trauma. 2008;65:535-543.
12. RandMD, Lock JB, van't Veer C, Giffney DP, Mann KG. Blood clotting in minimally altered whole blood. Blood. 1996;88:3432-3445.
13. Martini WZ, Pusateri AE, Uscilowicz JM, Delgado AV, Holcomb JB. Independent contributions of hypothermia and acidosis to coagulopathy in swine. J Trauma. 2005;58:1002-1009, discussion 1009-1010.
14. Martini WZ, Dubick MA, Pusateri AE, Park MS, Ryan KL, Holcomb JB. Does bicarbonate correct coagulation function impaired by acidosis in swine? J Trauma. 2006;61:99-106.
15. Martini WZ. Coagulopathy by hypothermia and acidosis: mechanisms of thrombin generation and fibrinogen availability. J Trauma. 2009;67: 202-208, discussion 208-209.
16. Harrigan C, Lucas CE, Ledgerwood AM. The effect of hemorrhagic shock on the clotting cascade in injured patients. J Trauma. 1989;29:1416-1421, discussion 1421-1412.
17. Harrigan C, Lucas CE, Ledgerwood AM, Walz DA, Mammen EF. Serial changes in primary hemostasis after massive transfusion. Surgery. 1985;98: 836-844.
18. Lucas CE, Ledgerwood AM, Saxe JM, Dombi G, Lucas WF. Plasma supplementation is beneficial for coagulation during severe hemorrhagic shock. Am J Surg. 1996;171:399-404.
19. Rahe-Meyer N, Pichlmaier M, Haverich A, et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth. 2009;102:785-792.
20. Plotkin AJ, Wade CE, Jenkins DH, et al. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma. 2008;64: S64-S68.
21. Li YF, Spencer FA, Becker RC. Comparative efficacy of fibrinogen and platelet supplementation on the in vitro reversibility of competitive glycoprotein IIb/IIIa (alphaIIb/beta3) receptor-directed platelet inhibition. Am Heart J. 2001;142:204-210.
22. Velik-Salchner C, Haas T, Innerhofer P, et al. The effect of fibrinogen concentrate on thrombocytopenia. J Thromb Haemost. 2007;5: 1019-1025.
23. Lorand L. Factor XIII and the clotting of fibrinogen: from basic research to medicine. J Thromb Haemost. 2005;3:1337-1348.
24. Lorand L. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann NY Acad Sci. 2001;936:291-311.
25. Haas T, Fries D, Velik-Salchner C, Relf C, Klingler A, Innerhofer P. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesth Analg. 2008;106: 1360-1365.